Particle.news
Download on the App Store
8 ARTICLES
·
5d ago

NHS Launches AI Blood Test Trial for Early Cancer Detection

The miONCO-Dx test, developed by Xgenera and the University of Southampton, aims to detect 12 cancers with 99% accuracy and reduce invasive procedures.

Medical technologist doing a blood draw services for patient. lab assistant with sterile rubber gloves taking blood sample from patient
Dame Deborah James, the podcast presenter, died six years after being diagnosed
image: ©CHUTIPON LAKKAEW | iStock
Image

Overview

  • The NHS has begun a clinical trial involving 8,000 patients to validate the miONCO-Dx blood test, which uses AI to detect cancers early through microRNA analysis.
  • Initial studies on 20,000 patients demonstrated the test's 99% accuracy in identifying 12 common cancers, including bowel, lung, breast, and prostate cancers.
  • The £2.4 million government-backed trial seeks to confirm the test’s effectiveness and pave the way for a potential NHS rollout within two years.
  • The test could replace invasive diagnostics like colonoscopies and biopsies, improving patient experience and saving NHS resources.
  • The BowelBabe Laboratory, named after campaigner Dame Deborah James, will spearhead research on bowel cancer and support the development of innovative detection methods.